Mucormycosis Unmasked: Advances in Pathogenesis and Emerging Therapeutic Frontiers

Dear Colleagues,

Mucormycosis is a rapidly progressing and often fatal fungal infection that has garnered increasing global attention in recent years, particularly among immunocompromised and critically ill patients. Despite its growing clinical relevance, many aspects of its pathogenesis remain elusive, and treatment options are still limited and often ineffective. With this Special Issue, “Mucormycosis Unmasked: Advances in Pathogenesis and Emerging Therapeutic Frontiers”, we aim to provide a platform for advancing our collective understanding of this neglected but devastating disease.

We invite original research articles, reviews, and short communications that explore the pathobiology of mucormycosis, host–pathogen interactions, diagnostic tools, and novel therapeutic strategies. Special emphasis will be placed on translational and interdisciplinary studies that bridge the gap between bench and bedside—bringing together insights from basic science, clinical research, and emerging therapeutic approaches, including antifungal development, immunotherapies, and biomarker discovery.

This Special Issue will serve as a curated resource for mycologists, infectious disease specialists, immunologists, and drug development researchers dedicated to understanding and addressing mucormycosis. Our goal is to highlight cutting-edge research and foster collaboration in order to drive innovation and improve outcomes for affected patients.

We warmly welcome your contributions and look forward to your participation in this important collection.

Warm regards,

Dr. Eman Youssef
Prof. Dr. Ashraf Ibrahim
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.